期刊文献+

组织因子途径在急性心肌梗死患者发作期间的比值变化及其意义

Change of Tissue Factor Pathway Ratio during Attack in Patients with Acute Myocardial Infarction and Its Clinical Significance
下载PDF
导出
摘要 本研究旨在观察急性心肌梗死(AMI)患者发作期间组织因子途径(TFP)的变化及其意义。采用手工法检测血浆复钙时间,酶联免疫吸附法(ELISA)检测血浆中的组织因子(TF)、组织因子途径抑制物(TFPI)、凝血因子Ⅶ抗原(FⅦ:Ag)、激活的FⅦ(FⅦa)及D-二聚体(D-dimer),采用发色底物法检测TF活性(TFact);采用一期凝固法测定凝血因子Ⅶ促凝活性(FⅦ:C)。观察对象包括59名AMI患者和84名健康中老年人。结果表明,①AMI患者血浆复钙时间比正常对照者明显缩短(p<0.01);②与对照组相比,AMI患者血浆中TF活性无显著增高(p>0.05);TF与TFPI的抗原均显著增加(p<0.01),但TF增高程度较TFPI更为显著,故TF/TFPI比值升高;总TFPI(t-TFPI)和全长TFPI(fl-TFPI)含量明显增加(p<0.01),截短TFPI(tr-TFPI)含量明显降低(p<0.01),TF/t-TFPI比值高于正常组,TF/fl-TFPI比值低于正常组(p<0.05),但在AMI组TF/tr-TFPI与fl-TFPI/t-TFPI比值明显高于对照组(p<0.01),而tr-TFPI/t-TFPI与tr-TFPI/fl-TFPI比值降低(p<0.01);③与对照组比较,血浆FⅦ∶C、FⅦa在AMI组是增高的(p<0.05),FⅦ∶Ag无显著性变化,FⅦa/FⅦ∶Ag比值明显升高(p<0.01),但FⅦa/FⅦ∶C及FⅦ∶C/FⅦ∶Ag比值并无显著性差异(p>0.05);④与正常对照组相比,AMI组D-dimer明显增高(p<0.01)。结论:AMI发作期间体内TFP被启动,提示AMI患者血液呈现高凝状态,为评估AMI及其危险事件的发生,以多因子同时测定为好,而且用相对比值表示高凝状态与危险因子比单测更为可靠。 This study was aimed to investigate the change of tissue factor pathway (TFP) ratio during the attack of acute myocardial infarction (AMI) and its clinical significance. Plasma recalcification time was assayed by manual operation. Plasma tissue factor ( TF), TF pathway inhibitor (TFPI) antigen, FⅦ: Ag, activated F Ⅶ ( FⅦa) and D- Dimer were measured by enzyme linked immunoabsorbent assay (ELISA). TF activity was determined by chromogenic assay, plasma FⅦ coagulation activity (FⅦ:C) was detected by one-stage system. Blood samples were taken from 59 patients with AMI and 84 healthy volunteers. The results indicated that ( 1 ) plasma recalcification time was significantly shorter in the AMI group than that in the control; (2)compared with the control, TF activity in AMI patients showed no significant change (p 〉 0.05 ) ; the antigen levels of TF and TFPI in patients with AMI were remarkably increased (p 〈 0.05), and the increment degree of TF was remarkably higher than that of TFPI, therefore the TF/TFP1 ratio was enlarged; total TFPI (t-TFPI) and full-length TFPI (fl-TFPI) were significantly higher (p 〈 0.01 ), truncated TFPI (tr-TFPI) was significantly lower (p 〈0.01 ); the TF/t-TFPI ratio was higher than that in normal group, the TF/t-TFPI ratio was lower than that in normal group (p 〈 0.01 ), but the TF/tr-TFPI and fl-TFPI/t-TFPI ratios in AMI group were more remarkably higher than that in control group (p 〈 0.01 ), the tr-TFPI/t-TFPI and tr-TFPI/fl-TFPI ratios were significantly lower (p 〈0.01 ) ; (3) compared with the control, the levels of plasma FⅦa and FⅦ: C in AMI group were higher (p 〈 0.05 ), F Ⅶ: Ag did not significatly change; FⅦa/FⅦ: Ag ratio was more remarkably higher (p 〈 0.01 ), but the elevation of F Ⅶa/FⅦ: C and F Ⅶ: C/FⅦ: Ag ratios showed no significant change (p 〉 0.05) ; (4) plasma D-dimer was significantly higher, compared with the normal control (p 〈 0.01 ). It is concluded that TFP is initiated during the attack of AMI, suggesting the circulating blood in AMI patients is in hypercoagulable status, therefore the simultaneous detection of multiple coagulation factors is necessary for evaluating risk factors in AMI patients, and the use of ratio for reflecting hypercoagulable status and risk factors is more reliable to detect each of them separately.
出处 《中国实验血液学杂志》 CAS CSCD 2009年第1期198-202,共5页 Journal of Experimental Hematology
关键词 心肌梗死 组织因子 组织因子途径抑制物 凝血因子Ⅶ D-二聚体 myocardial infarction tissue factor tissue factor pathway inhibitor Factor Ⅶ D-dimer
  • 相关文献

参考文献12

  • 1Brodin E, Borvik T, Sandset PM, et al. Coagulation activation in young survivors of myocardial infarction (MI) -a population-based ease-control study. Thromb Haemost, 2004 ; 92 : 178 - 184.
  • 2Morange PE, Simon C, Alessi MC, et al. Endothelial cell markers and the risk of coronary heart disease: the prospective epidemiological study of myocardial infarction ( PRIME ) study. Circulation, 2004;109 : 1343 - 1348.
  • 3Golino P, Ravera A, Ragni M, et al. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation, 2003 ; 108:2864 - 2869.
  • 4Steppich B, Mattisek C, Sobczyk D, et al. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost, 2005 ;93:35 - 39.
  • 5Bennermo M, Held C, Ericsson CG, et al. Genotype-specific increase in plasma concentrations of activated coagulation factor Ⅶ in response to experimental inflammation. A link between infection and acute myocardial infarction7 Thromb Haemost, 2005 ; 94 : 427 -431.
  • 6He M, Wen Z, He X, et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res, 2002;107:223 - 228.
  • 7贺蓉,贺石林.凝血-抗凝血系统与血栓.见:刘泽霖,贺石林,李家增主编.血栓性疾病的诊断与治疗(第2版).北京:人民卫生出版社.2006:100-102.
  • 8陈南,华守明,卢辉和,王毅,盛臻强,管耘园.D-二聚体与纤维蛋白原在冠心病中的临床意义[J].中国微循环,2006,10(2):143-145. 被引量:13
  • 9许建平,曹燕娜,文志斌,刘发益,熊石龙,马志成,何晓凡,李俊成,贺石林.急性心脑血管血栓性疾病患者血浆FⅦ:C、FⅧ:C、凝血酶原及纤维蛋白原的变化[J].血栓与止血学,2001,7(2):53-56. 被引量:4
  • 10Ardissino D, Merlini PA, Arlens R, et al. Tissue factor in human coronary atherosclerotic plaques. Clin Chim Acta,2000 ;291:235 - 240.

二级参考文献22

  • 1刘敏涓,周立红,高聪.缺血性脑卒中患者血清胆固醇与三酰甘油对血浆中凝血因子Ⅶ的影响[J].血栓与止血学,1999,6(4):150-152. 被引量:1
  • 2赵世民.纤维蛋白原的病理生理[J].微循环技术杂志(临床与实验),1996,4(2):104-106. 被引量:1
  • 3[7]Ho C, Wang S, Jap T. Hemostatic risk ractors of coronary artery disease in the Chinese. Int J Cardiol, 1995, 51:79-84.
  • 4[8]Smith FB, Lee A J, Fowkes FGR, et al. Himostatic factors as predictors of ischemic heart disease and stroke in the Edingurth Artery Study. Arterioscler Thromb Vase Biol, 1997, 17:3321-3325.
  • 5[9]Doggen CJM, Manger Cats V, Bertina RM, et al. A genetic propensity to high factor Ⅶ is not associated with the risk of myocardial infarction in men. Thromb Haemost, 1998, 80:281-285.
  • 6[10]Folsom AR, Wu KK, Daivs CE, et al. Population correlates of plasma fibrinogen and factor Ⅶ, putative cardiovascular risk factor.Atherosclerosis, 1991,911: 91-205.
  • 7[11]Ernst E, Resch K. Fibrinogen as a cardiovascular risk factor: a metaanalysis and review of the literature. Ann Intern Med, 1993, 118:956-963.
  • 8[12]Rice Gl, Grant PJ. FⅧ coagulant activity and antigen in subjects with ischemia heart disease. Thromb Haemost, 1998, 80:757-762.
  • 9[13]Mansvelt EPG, LaffanM, Mevey JH, et al. Analysis of the F8 gene in individuals with high plasma factor Ⅶ: C levels and associated venous thrombosis. Thromb Haemost, 1998, 80: 561-565.
  • 10[14]Rosendaal FR, Siscovick DS, Schwartz SM, et al. A common prothrombin variant (20210 G to A) increase the risk of myocardial infarction in Young Women. Blood, 1997, 90(5):1747-1750.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部